RECRUITING

Extensions of Resurgence as Choice

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Although behavioral treatments for decreasing destructive behavior, such as differential reinforcement of alternative behavior (DRA), are effective in the clinic, problem behavior often returns when a caregiver does not give the child their way in the natural environment (e.g., caregiver is busy with an infant sibling). This form of treatment relapse is known as resurgence. The goal of the current study is to evaluate whether alternating sessions in which the child can have their way (i.e., "on" sessions) with sessions in which the child can not have their way (i.e., "off" sessions) helps to mitigate resurgence.

Official Title

Extensions of Resurgence as Choice: Basic and Clinical Studies

Quick Facts

Study Start:2023-02-01
Study Completion:2028-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05537610

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:3 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. 1. boys and girls from ages 3 to 17;
  2. 2. problem behavior that occurs at least 10 times a day, despite previous treatment;
  3. 3. problem behavior maintained by social positive reinforcement;
  4. 4. stable protective supports for self-injurious behavior (e.g., helmet) with no anticipated changes during enrollment;
  5. 5. on a stable psychoactive drug regimen for at least 10 half-lives per drug or drug free;
  6. 6. stable educational plan and placement with no anticipated changes during the child's treatment.
  1. 1. patients who do not meet the inclusion criteria;
  2. 2. patients currently receiving 15 or more hours per week of treatment for their problem behavior;
  3. 3. DSM-5 diagnosis of Rett syndrome or other degenerative conditions (e.g., inborn error of metabolism);
  4. 4. a comorbid health condition or major mental disorder that would interfere with study participation;
  5. 5. occurrence of self-injury during study assessments that presents a risk of serious or permanent harm (e.g., detached retinas) based on our routine clinical-risk assessment;
  6. 6. patients requiring changes to protective supports for self-injury or drug treatment, but we will invite these patients to participate when protective supports and drug regimen are stable.

Contacts and Locations

Study Contact

Brian Greer, PhD
CONTACT
8488008505
brian.greer@rutgers.edu
Serena Claiborne
CONTACT
8488008504
SClaiborne@childrens-specialized.org

Study Locations (Sites)

Children's Specialized Hospital-Rutgers University Center for Autism Research, Education, and Services
Somerset, New Jersey, 08873
United States

Collaborators and Investigators

Sponsor: Rutgers, The State University of New Jersey

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-01
Study Completion Date2028-01-31

Study Record Updates

Study Start Date2023-02-01
Study Completion Date2028-01-31

Terms related to this study

Additional Relevant MeSH Terms

  • Problem Behavior
  • Aggression
  • Self-Injury